A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Gene data from HGNC • Click to view on NCBI Gene
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Online Mendelian Inheritance in Man
European rare disease database
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning colorectal cancer
Updated Feb 3, 2026
Kahimmune Therapeutics has secured a licensing agreement with Gustave Roussy and SATT Paris-Saclay to develop a vaccine targeting colorectal and pancreatic cancers. This collaboration marks a significant step in advancing innovative cancer therapies.
A new CDC report highlights that increased screening could significantly reduce colorectal cancer rates, which is currently the second leading cause of cancer deaths in the U.S. The report indicates a decline in both incidence and mortality rates among adults.
CDC will hold a media briefing to discuss the latest Vital Signs report on colorectal cancer screening, incidence, and mortality trends in the United States from 2002 to 2010. This briefing aims to raise awareness about the importance of screening in reducing mortality rates.
A CDC study reveals that over 75% of primary care physicians prefer in-office fecal occult blood tests for colorectal cancer screening, despite home-based tests being more accurate. This highlights a significant gap in screening practices that could impact early detection efforts.
The CDC has allocated $22 million to support colorectal cancer screening programs across 26 states and tribal organizations, targeting low-income individuals aged 50-64 who are underinsured or uninsured. This initiative aims to improve access to vital screening services for a vulnerable population.